Zobrazeno 1 - 10 of 38 pro vyhledávání: '"K, Gilder"'
2
Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity
Autor: P. Klassen, Ronette L. Kolotkin, K. Gilder, Frank L. Greenway, S. Chen
Publikováno v: Clinical Obesity. 5:237-244
Summary Weight loss is associated with improved quality of life in some, but not all, weight loss trials. We evaluated changes at 56 weeks in quality of life, measured by the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire, in a p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc0ebac9f40600c27fcc7656386c309c
https://doi.org/10.1111/cob.12108
Zobrazit plný text záznamu
3
Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion
Autor: A, Halseth, K, Shan, K, Gilder, M, Malone, L, Acevedo, K, Fujioka
Publikováno v: Obesity Science & Practice
Summary Objective This multicenter, randomized, controlled, open‐label trial examined weight‐related quality of life, control over eating behaviour and sexual function after 26 weeks of treatment with either 32 mg naltrexone sustained release (SR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dd01faf4a88e1bb0cf20da511af021d8
https://pubmed.ncbi.nlm.nih.gov/29670752
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy
Autor: Raymond A Plodkowski, Patrick M. O'Neil, Frank L. Greenway, K Gilder, Ken Fujioka, B Walsh
Publikováno v: International journal of obesity (2005). 40(9)
Weight management medications increase the likelihood that patients will achieve clinically meaningful improvements in cardiovascular, metabolic and other weight-related measures of health. However, the weight loss achieved with any weight management
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435152d64c1aae6115427eb8468aabec
https://pubmed.ncbi.nlm.nih.gov/27328752
Zobrazit plný text záznamu
9
Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity
Autor: R L, Kolotkin, S, Chen, P, Klassen, K, Gilder, F L, Greenway
Publikováno v: Clinical obesity. 5(5)
Weight loss is associated with improved quality of life in some, but not all, weight loss trials. We evaluated changes at 56 weeks in quality of life, measured by the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire, in a pooled an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b8ed0867162f4a5697e3905580a22c64
https://pubmed.ncbi.nlm.nih.gov/26222044
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje